Private Capital Group, LLC Supernus Pharmaceuticals, Inc. Transaction History
Private Capital Group, LLC
- $133 Million
- Q2 2022
A detailed history of Private Capital Group, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 263 shares of SUPN stock, worth $9,541. This represents 0.01% of its overall portfolio holdings.
Number of Shares
263
Previous 281
6.41%
Holding current value
$9,541
Previous $9,000
11.11%
% of portfolio
0.01%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding SUPN
# of Institutions
281Shares Held
60.6MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$377 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$222 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$185 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$105 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$95.5 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.94B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...